Moneycontrol
    Moneycontrol PRO
    LAMF
    LAMF

    Cadila Healthcare

    Jump to

    • Zydus Lifesciences jumps over 5% after US arm buys global rights for BridgeBio's Nulibry

    • Accumulate Cadila Healthcare; target of Rs 445: KR Choksey

    • Buy Cadila Healthcare; target of Rs 560: Sharekhan

    • Buy Cadila Healthcare; target of Rs 490: Motilal Oswal

    • Cadila Health Consolidated December 2021 Net Sales at Rs 3,655.00 crore, down 3.7% Y-o-Y

    • Cadila Health Standalone December 2021 Net Sales at Rs 1,830.30 crore, down 4.61% Y-o-Y

    • Hot Stocks | Here's why you should buy Maruti Suzuki, Cadila Healthcare for short term

    • Cadila re-appoints Sharvil P Patel as MD for another five-year term

    • Cadila Healthcare Q3 PAT seen up 3.2% YoY to Rs 544 cr: Prabhudas Lilladher

    • Buy Cadila Healthcare: target of Rs 720: Sharekhan

    • Cadila Health Standalone September 2021 Net Sales at Rs 2,008.90 crore, down 2.33% Y-o-Y

    • Cadila Healthcare Q2 PAT seen up 19% YoY to Rs 563.3 cr: Prabhudas Lilladher

    • Cadila Healthcare enters pact with Shilpa Medicare for production of ZyCoV-D vaccine

    • Cadila Healthcare share price falls on sale of two brands

    • Cadila Healthcare unit inks pact to sell two brands to Integrace

    • Buy Cadila Healthcare target of Rs 695: Prabhudas Lilladher

    • Buy Cadila Healthcare; target of Rs 720: Sharekhan

    • Cadila: Vaccine opportunity unfolds

    • Cadila Healthcare share price rises 7% after DCGI approves ZyCoV-D COVID vaccine

    • Buy Cadila Healthcare; target of Rs 670: Motilal Oswal

    • What should investors do with Cadila Healthcare after Q1 earnings: buy, sell or hold?

    • Cadila Health Consolidated June 2021 Net Sales at Rs 4,025.40 crore, up 10.59% Y-o-Y

    • Cadila Health Standalone June 2021 Net Sales at Rs 2,123.40 crore, up 18.24% Y-o-Y

    • Cadila Healthcare arm completes sale of animal health business for Rs 2,921 crore

    • Cadila Healthcare Q1 PAT seen up 63.9% YoY to Rs 744 cr: KRChoksey

    Advisory Alert:

    It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347